Martin Dietrich, MD, PhD

Martin F. Dietrich, MD, PhD is Board-certified in internal medicine and medical oncology. In his clinical practice, he addresses all aspects of hematologic and oncologic care, with a special research interest in the treatment of lung and breast cancer, and genetic evaluation and counseling of somatic and hereditary syndromes. He also holds a faculty appointment at the University of Central Florida in Orlando as an assistant professor of internal medicine.

Dr. Dietrich holds doctorates in cancer biology from the German Cancer Research Center, Heidelberg, Germany and in molecular genetics from the University of Texas Southwestern Graduate School. He completed his fellowships in Hematology/Oncology in the physician-scientist training track at the University of Texas Southwestern Track as a T32 scholar of the National Cancer Institute. His expertise in molecular genetics translates into a clinical philosophy of matching tailored therapies to each patient’s individual tumor biology.

A principal investigator in numerous precision medicine-based trials, Dr. Dietrich is focusing on the clinical development of novel anti-cancer agents. He also conducts clinical-translation research in genetic testing modalities, “liquid” biopsies and the optimization of diagnostic findings.

As a fellow of the American College of Physicians (FACP) and a Board-certified internist, Dr. Dietrich believes in a comprehensive approach to his patients’ medical care.

He is a member of the American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), American Association for Cancer Research (AACR), American Society of Hematology (ASH) and the European Society of Medical Oncology (ESMO).

He has authored numerous peer-reviewed articles published in Cancer Cell, Cancer Research, Blood, Oncogene, Journal of Thoracic Oncology, Journal of Oncology Practice and JAMA Oncology, as well as book chapters and abstracts. He has lectured extensively both nationally and internationally on the topics of molecular genetics, immunotherapies and thoracic malignancies.